Upcoming Free CME
FOR ICUS WEBINARS AND FREE CME
Cardiovascular CEUS - Implementing Guideline defined Contrast Echocardiography in daily clinical practice
An ICUS live webinar
Monday, January 25, 2021
Full details available soon!
Highlights of Rotterdam Bubble Conference 2020
Watch CEUS demonstrations
Watch hands-on CEUS demonstrations performed by expert echocardiographers at the 2019 Hammersmith Echocardiology Conference in London. There is no cost to view the demonstrations.
To watch, click here
Special thanks to ICUS board members Petros Nihoyannopoulos, Mark Monaghan and Sharon Mulvagh, and to LiveMedia, for making these educational experiences available to ICUS.
FREE WEBINARS – Intro to CEUS
FREE WEBCASTS – ICUS Educational Programs
ICUS urges FDA to Remove Boxed Warnings on Ultrasound Contrast Agents - cites citing compelling scientific data demonstrating their safety and life-saving potential. (August 31, 2020)
More Doctors Are Turning to Radiation-free CEUS Scans for Imaging Children Says ICUS (December 2, 2019)
Microbubbles and Ultrasound Can Help Treat Heart Attacks (September 6, 2019)
CEUS Safely Assesses Suspected Liver Tumors in Pregnant Women (September 5, 2019)
CEUS Helps Diagnose Infant Brain Injury and Predict Outcomes (September 5, 2019)
Tiny Bubbles Help Doctors Predict Risk of Heart Attack and Stroke (September 5, 2019)
Simple CEUS Scan Helps Diagnose Liver Cancer When MRI is Uncertain (September 5, 2019)
Ultrasound Societies Urge FDA to Remove “Black Box” on Ultrasound Contrast Agents (March 5, 2019)
Physicians predict “sea change” for contrast ultrasound use (November 26, 2018)
More ICUS Press Releases
CEUS STAKEHOLDER PORTALS:
ICUS Weekly News Monitor
- October 23, 2020
- October 19, 2020
- October 19, 2020
- October 17, 2020
- October 12, 2020
- September 30, 2020
ICUS Bubble Blog
The ICUS Bubble Blog showcases real-life CEUS experiences from around the world, with a special focus on how CEUS impacts individual patients and their care.
by Dr. Lisa Johnson Resident, Department of Radiology, University of Washington, Seattle, WA
Ms. S is a 64-year old Cambodian woman with chronic active hepatitis B currently being treated with tenofivir alafenamide fumarate, a medication to treat the viral infection of her liver.
She has no radiologic or laboratory evidence of cirrhosis and has been undergoing screening abdominal ultrasounds every six months according to international guidelines due to her increased risk for liver cancer given the diagnosis of hepatitis B, which have been unremarkable. Her most recent right upper quadrant ultrasound demonstrated as an incidental finding a newly appeared solid oval area in the midportion of the right kidney without internal vascularity.
More Bubble Blogs
- UCA Alters Diagnosis and Treatment of COVID-Positive Patient
- CEUS Helps Rule Out Gallbladder Cancer
- CEUS helps rule out pancreatic cancer
- Young girl recovers from acute kidney failure after CEUS pinpoints cause
- CEUS rules out liver cancer where MR and CT were unsuccessful
- CEUS leads to life-saving surgery
- CEUS Identifies Ovarian Tumor